Ronald Kool
@dr_rkool
Followers
102
Following
166
Media
10
Statuses
89
Husband, father, MD, PhD candidate @mcgillu. Uro-oncologist at Erasto Gaertner Hospital - Curitiba, Brazil.
Curitiba, Brazil
Joined October 2019
RT @tompowles1: POTOMAC trial- Durvalumab + BCG shows positive results for DFS in high-risk NMIBC vs BCG alone. sasanlimab (CREST) also had….
0
56
0
RT @wroclawski_uro: 🥨 SunRise 4 shows NeoAdj TAR 200 +/- cetrelimab is safe.- ☣️Low G3 toxicity .- ⛔️Low treatment discontinuation .- 🔪No….
0
7
0
RT @ThiagoHotaUro: #HoLEP as a safe option for deobstruction in the setting of advanced prostate adenocarcinoma, T4 lesion is not a restric….
0
8
0
RT @EurUrolOncol: Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based The….
0
5
0
RT @WesKassouf: Congratulations @gautiermarcq @dr_rkool and all on moving this field forward. As patients’ profiles who opt for #chemoradia….
0
3
0
RT @gautiermarcq: Just in 👉 @JCO_ASCO Benefit of Whole-Pelvis Radiation ☢️ for Patients With #MIBC . . 👇👇👇TWEETOR….
0
39
0
RT @Prof_Nick_James: Really important and been saying this for many years so good to see other sources supporting. Extent of debulking prog….
0
25
0
RT @WesKassouf: Following IPTW, complete transurethral resection prior to radiation therapy for muscle-invasive bladder cancer was not asso….
0
7
0
RT @OncoAlert: Effect of complete transurethral resection on oncologic outcomes after radiation therapy for muscle-invasive bladder cancer….
0
17
0
RT @AarmstrongDuke: Great session discussing evolving mCRPC treatments here in Curitiba Brazil with @JnatasP82450795 and @dr_rkool! @DukeGU….
0
4
0
RT @Markuseckstein3: FGFR3 mutations are frequent alterations in urothelial cancer, but 🚨:.➡️ NMIBC: ~50% are mutated.➡️ MIBC: ~10% are mut….
0
28
0
RT @drenriquegrande: ⚡️ Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-bas….
0
10
0
This is another paper based on our Canadian Collaborative retrospective database of patients with #MIBC treated bladder preservation. @GSK_UofT.@gautiermarcq.@RodBreau.@BobbyShayegan.@dr_cury.@Nimira_A.@siemensr .@pcvblack.@WesKassouf.
0
0
4
Happy to share our work on the Benefit of Neoadjuvant Cisplatin-based Chemotherapy followed by curative Radiation in muscle-invasive bladder cancer .
3
5
17
RT @TomFlaigMD: The @NCCN Bladder Cancer Guidelines v1.2024 are now available. It has been a very active time in bladder cancer therapeut….
0
33
0
RT @WesKassouf: @charleshesswani and Chelsea Jackson showing immunohistochemistry-based #MIBC molecular subtyping was not associated with r….
0
5
0
RT @EurUrolOpen: Feasibility and Impact of Immunohistochemistry-based Molecular Subtyping for Muscle-invasive Bladder Cancer in Patients Tr….
0
6
0
Very happy and grateful to be part of it!. @gautiermarcq @RodBreau @pcvblack @BobbyShayegan @DanielHalstuch @BuscaIon @ham_neg @MTDawidek @GaganFervaha @dr_cury @Nimira_A @siemensr @GSK_UofT @WesKassouf
0
2
8
It was great to reconnect with so many friends at #AUA23 in Chicago. Based on our collaborative Canadian database on patients with muscle-invasive #bladdercancer treated with RT-based #bladderpreservation we presented:. 2 moderated posters.3 podium presentations
4
1
16